What is NDC 73207-101?

73207-101 is the product NDC for Qinlock (ripretinib), Ripretinib 50 mg/1 tablet, listed with the FDA by Deciphera Pharmaceuticals, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Deciphera Pharmaceuticals, LLC, NDC labeler code 73207. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Qinlock?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Qinlock NDC 73207-101 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73207-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73207-0101Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73207-101-30	73207010130	1 BOTTLE in 1 CARTON (73207-101-30) / 90 TABLET in 1 BOTTLEMarketed from May 15, 2020
73207-101-31	73207010131	1 BOTTLE in 1 CARTON (73207-101-31) / 30 TABLET in 1 BOTTLEMarketed from May 15, 2020 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Qinlock
Generic name (nonproprietary): ripretinib
Active ingredients: Ripretinib — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Deciphera Pharmaceuticals, LLCNDC labeler code 73207
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 213973
Marketing start: May 15, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)Platelet-derived Growth Factor alpha Receptor Inhibitors (Mechanism)Stem Cell Factor (KIT) Receptor Inhibitors (Mechanism)
Identifiers: Product ID 73207-101_142c8672-a552-4d20-9226-2a92aa9773d1SPL ID 142c8672-a552-4d20-9226-2a92aa9773d1SPL set ID 9f18e462-03dd-4296-a02a-a0577e3ee78dRxCUI 2369397, 2369403UNII 9XW757O13D
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473207010130 followed by a unit qualifier and the quantity

Package 73207-0101-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 12, 2025.

Indications (excerpt from the label)

QINLOCK is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib. QINLOCK is a kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73207-101

What is NDC 73207-101?: 73207-101 is the product NDC for Qinlock (ripretinib), Ripretinib 50 mg/1 tablet, listed with the FDA by Deciphera Pharmaceuticals, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Qinlock (Ripretinib).
What is the active ingredient?: Ripretinib.
Who is the labeler?: Deciphera Pharmaceuticals, LLC, NDC labeler code 73207. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Qinlock?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Qinlock (Ripretinib) NDC 73207-101